GlobeNewswire
Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma and Findings from BEACON Study Internal Investigation
📈
AI Sentiment
Highly Positive
8/10
- Home
- JSPR
as of 12-03-2025 10:07am EST
$1.48
$0.08
-5.14%
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
Chart Type:
Time Range:
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | REDWOOD CITY |
| Market Cap: | 68.4M | IPO Year: | N/A |
| Target Price: | $25.60 | AVG Volume (30 days): | 3.3M |
| Analyst Decision: | Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.79 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.56 - $26.05 | Next Earning Date: | 11-10-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered JSPR Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 15 hours ago
AI Recommendation
hold
Model Accuracy: 72.19%
72.19%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Jasper Therapeutics Inc. News
JSPR Breaking Stock News: Dive into JSPR Ticker-Specific Updates for Smart Investing
GlobeNewswire
Jasper Therapeutics to Host an Investor Webinar on December 2nd to Present Preliminary Data from ETESIAN Study in Asthma and Findings from BEACON Study Investigation
📊
AI Sentiment
Positive
6/10
Compare JSPR vs Leading Stocks
See how JSPR stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "JSPR Jasper Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.